The first study, published yesterday in Clinical Infectious Diseases, includes results of a phase 3 clinical trial (MELODY), ...
UPMC Children’s Community Pediatrics is seeing an increase in cases of flu, COVID, RSV, viral sore throats and a viral cough ...
China's Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK's shingles ...
Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) ...
Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...
Cases of respiratory syncytial virus, or RSV, are widespread across the area – even as providers at Pediatric Care Specialists continue seeing young patients for a continued trend of "walking ...
GSK said on Thursday it had expanded its agreement with China's largest vaccine company Zhifei to explore a potential ...
Under the revised agreement, the two have taken their RSV commitment a step forward as Zhifei agrees to engage exclusively ...
Weekly data shows that cases of RSV and COVID-19 are down more than 80% compared to the same week in a typical season.
Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
As family members gather at each other's houses this holiday season, illness might tag along. Here's what you need to know ...